压力性损伤风险预测工具的准确性与临床有效性:一项伞状综述
该伞状综述依据Cochrane指南,纳入26篇系统综述,评估成人压力性损伤风险预测工具的预后准确性与临床有效性。19篇系统综述评估70种工具的准确性,量表敏感度53%至97%、特异度46%至84%;11篇评估临床有效性,仅2项随机试验且均高偏倚风险,未发现对压力性损伤发生率有影响。结论认为缺乏高质量证据支持其准确性,可靠的有效性证据有限,需进一步研究。
要点
- 量表敏感度53%至97%、特异度46%至84%,仅2/19篇系统综述进行了恰当的统计合并与质量评价。
- 机器学习模型报告高准确性,但部分数据源于模型开发数据,结果可能过于乐观。
- 2项随机试验均高偏倚风险,未发现风险预测工具对压力性损伤发生率有影响。
核心结论
- 现有系统综述表明,压力性损伤风险预测工具的准确性缺乏高质量证据,其使用可减少压力性损伤发生率的可靠证据有限。
- 需要进一步研究以确立恰当开发并验证的压力性损伤风险预测工具的临床有效性。
研究设计与样本
- 伞状综述,依据Cochrane指南开展,检索MEDLINE、Embase、CINAHL、EPISTEMONIKOS(自建库至2024年6月)、Google Scholar(2013年至2024年)及参考文献列表。
- 纳入26篇系统综述,其中19篇评估预后准确性、11篇评估临床有效性,4篇同时评估两方面。
- 纳入标准为评估任何临床环境中成人压力性损伤风险预测工具准确性或临床有效性的系统综述;排除儿科工具、仅传感器工具及现有压力性损伤分期/诊断研究。
- 采用改编的AMSTAR-2标准评价方法学质量,结果以叙述性方式描述。
主要发现
- 19篇预后准确性系统综述评估70种工具,包括39种量表和31种机器学习模型,Braden、Norton、Waterlow、Cubbin-Jackson量表及其修改版评估最多。
- 来自聚焦纳入系统综述的Meta分析显示,量表敏感度范围为53%至97%,特异度范围为46%至84%。
- 仅2/19(11%)篇系统综述进行了恰当的统计合并和质量评价。
- 2篇评估机器学习算法的系统综述报告了高预后准确性估计,但部分数据来源于模型开发所用数据,可能导致结果过于乐观。
- 11篇临床有效性系统综述中识别出2项随机试验评估压力性损伤风险评估工具对发生率的影响,均纳入一项Cochrane系统综述且评为高偏倚风险,两项试验均未发现对压力性损伤发生率有影响的证据。
关键数值与推荐
- 量表敏感度范围为53%至97%,特异度范围为46%至84%。
- 仅2/19(11%)篇预后准确性系统综述进行了恰当的统计合并和质量评价。
- 2项随机试验均评为高偏倚风险,均未发现对压力性损伤发生率有影响的证据。
临床怎么用
- 原文未据此给出推荐。
局限性
- 采用AMSTAR-2标准可能过于关注报告质量而非方法学质量,加之纳入系统综述报告质量较差。
- 未根据低AMSTAR-2评级排除系统综述,以提供全面概述。
- 过度依赖诊断试验准确性原则而非预后建模方法,后者未考虑预测的时间性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pressure injuries (PIs) pose a substantial healthcare burden and incur significant costs worldwide. Several risk prediction tools to allow timely implementation of preventive measures and a subsequent reduction in healthcare system burden are available and in use. The ability of risk prediction tools to correctly identify those at high risk of PI (prognostic accuracy) and to have a clinically significant impact on patient management and outcomes (effectiveness) is not clear. We aimed to evaluate the prognostic accuracy and clinical effectiveness of risk prediction tools for PI and to identify gaps in the literature. METHODS AND FINDINGS: The umbrella review was conducted according to Cochrane guidance. Systematic reviews (SRs) evaluating the accuracy or clinical effectiveness of adult PI risk prediction tools in any clinical settings were eligible. Studies on paediatric tools, sensor-only tools, or staging/diagnosis of existing PIs were excluded. MEDLINE, Embase, CINAHL, and EPISTEMONIKOS were searched (inception to June 2024) to identify relevant SRs, as well as Google Scholar (2013 to 2024) and reference lists. Methodological quality was assessed using adapted AMSTAR-2 criteria. Results were described narratively. We identified 26 SRs meeting all eligibility criteria with 19 SRs assessing prognostic accuracy and 11 assessing clinical effectiveness of risk prediction tools for PI (4 SRs assessed both aspects). The 19 SRs of prognostic accuracy evaluated 70 tools (39 scales and 31 machine learning (ML) models), with the Braden, Norton, Waterlow, Cubbin-Jackson scales (and modifications thereof) the most evaluated tools. Meta-analyses from a focused set of included SRs showed that the scales had sensitivities and specificities ranging from 53% to 97% and 46% to 84%, respectively. Only 2/19 (11%) SRs performed appropriate statistical synthesis and quality assessment. Two SRs assessing machine learning-based algorithms reported high prognostic accuracy estimates, but some of which were sourced from the same data within which the models were developed, leading to potentially overoptimistic results. Two randomised trials assessing the effect of PI risk assessment tools (within the full test-intervention-outcome pathway) on the incidence of PIs were identified from the 11 SRs of clinical effectiveness; both were included in a Cochrane SR and assessed as high risk of bias. Both trials found no evidence of an effect on PI incidence. Limitations included the use of the AMSTAR-2 criteria, which may have overly focused on reporting quality rather than methodological quality, compounded by the poor reporting quality of included SRs and that SRs were not excluded based on low AMSTAR-2 ratings (in order to provide a comprehensive overview). Additionally, diagnostic test accuracy principles, rather than prognostic modelling approaches were heavily relied upon, which do not account for the temporal nature of prediction. CONCLUSIONS: Available systematic reviews suggest a lack of high-quality evidence for the accuracy of risk prediction tools for PI and limited reliable evidence for their use leading to a reduction in incidence of PI. Further research is needed to establish the clinical effectiveness of appropriately developed and validated risk prediction tools for PI.
引用
- Hillier B, Scandrett K, Coombe A, et al. Accuracy and clinical effectiveness of risk prediction tools for pressure injury occurrence: An umbrella review. PLoS Med. 2025. PMID: 39913541. doi:10.1371/journal.pmed.1004518
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。